Upcoming clinical trial: The effect of Rebox current in pain management
In September 2023, a clinical trial "The effect of Rebox current in pain management" will start at F.D. Roosevelt University Hospital in Banská Bystrica, Slovakia. This post-marketing monocentric double-blind sham controlled crossover study will assess the efficacy of Rebox electrotherapy in the treatment of pain. Totally 72 patients will be treated with both real and sham Rebox device in a crossover design with a 1:1 ratio over a 6-week period. The degree of pain intensity reduction after the real Rebox stimulation will be evaluated in comparison with the sham stimulation. Moreover, differences in multidimensional aspects of pain will be compared between the real and sham stimulation. For more details, see clinicaltrials.gov.
Cooperation with Biomed Neurotechnologie
We are happy to announce the start of cooperation with Biomed Neurotechnologie. Since 2007, Biomed has been popularizing the latest achievements in the field of neuromodulation, neuropsychology, psychophysiology and pedagogy in Poland.
New Rebox-Physio 4 and Rebox-Physio tDCS models
COVID-19 pandemics situation
Despite currently severe situation due to COVID-19 pandemics in the Czech Republic, our production, service and research activities remain unaffected.
Rebox Therapy in Medical Biophysics textbook
Rebox therapy method has been included in 2nd edition of Czech Medical Biophysics textbook for general medicine students. The book can be purchased here.